BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38405854)

  • 1. Identification of retinal tau oligomers, citrullinated tau, and other tau isoforms in early and advanced AD and relations to disease status.
    Shi H; Mirzaei N; Koronyo Y; Davis MR; Robinson E; Braun GM; Jallow O; Rentsendorj A; Ramanujan VK; Fert-Bober J; Kramerov AA; Ljubimov AV; Schneider LS; Tourtellotte WG; Hawes D; Schneider JA; Black KL; Kayed R; Selenica MB; Lee DC; Fuchs DT; Koronyo-Hamaoui M
    bioRxiv; 2024 Feb; ():. PubMed ID: 38405854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylated tau in the retina correlates with tau pathology in the brain in Alzheimer's disease and primary tauopathies.
    Hart de Ruyter FJ; Morrema THJ; den Haan J; ; Twisk JWR; de Boer JF; Scheltens P; Boon BDC; Thal DR; Rozemuller AJ; Verbraak FD; Bouwman FH; Hoozemans JJM
    Acta Neuropathol; 2023 Feb; 145(2):197-218. PubMed ID: 36480077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unique Alzheimer's disease paired helical filament specific epitopes involve double phosphorylation at specific sites.
    Hoffmann R; Lee VM; Leight S; Varga I; Otvos L
    Biochemistry; 1997 Jul; 36(26):8114-24. PubMed ID: 9201960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinal pathological features and proteome signatures of Alzheimer's disease.
    Koronyo Y; Rentsendorj A; Mirzaei N; Regis GC; Sheyn J; Shi H; Barron E; Cook-Wiens G; Rodriguez AR; Medeiros R; Paulo JA; Gupta VB; Kramerov AA; Ljubimov AV; Van Eyk JE; Graham SL; Gupta VK; Ringman JM; Hinton DR; Miller CA; Black KL; Cattaneo A; Meli G; Mirzaei M; Fuchs DT; Koronyo-Hamaoui M
    Acta Neuropathol; 2023 Apr; 145(4):409-438. PubMed ID: 36773106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aluminum modifies the properties of Alzheimer's disease PHF tau proteins in vivo and in vitro.
    Shin RW; Lee VM; Trojanowski JQ
    J Neurosci; 1994 Nov; 14(11 Pt 2):7221-33. PubMed ID: 7525898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PHF-Core Tau as the Potential Initiating Event for Tau Pathology in Alzheimer's Disease.
    Luna-Viramontes NI; Campa-Córdoba BB; Ontiveros-Torres MÁ; Harrington CR; Villanueva-Fierro I; Guadarrama-Ortíz P; Garcés-Ramírez L; de la Cruz F; Hernandes-Alejandro M; Martínez-Robles S; González-Ballesteros E; Pacheco-Herrero M; Luna-Muñoz J
    Front Cell Neurosci; 2020; 14():247. PubMed ID: 33132840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The fluorescent ligand bTVBT2 reveals increased p-tau uptake by retinal microglia in Alzheimer's disease patients and App
    Nuñez-Diaz C; Andersson E; Schultz N; Pocevičiūtė D; Hansson O; ; Nilsson KPR; Wennström M
    Alzheimers Res Ther; 2024 Jan; 16(1):4. PubMed ID: 38167557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [F-18]-AV-1451 binding correlates with postmortem neurofibrillary tangle Braak staging.
    Marquié M; Siao Tick Chong M; Antón-Fernández A; Verwer EE; Sáez-Calveras N; Meltzer AC; Ramanan P; Amaral AC; Gonzalez J; Normandin MD; Frosch MP; Gómez-Isla T
    Acta Neuropathol; 2017 Oct; 134(4):619-628. PubMed ID: 28612291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble pre-fibrillar tau and β-amyloid species emerge in early human Alzheimer's disease and track disease progression and cognitive decline.
    Koss DJ; Jones G; Cranston A; Gardner H; Kanaan NM; Platt B
    Acta Neuropathol; 2016 Dec; 132(6):875-895. PubMed ID: 27770234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative
    Zhao Q; Liu M; Ha L; Zhou Y;
    Front Neurol; 2019; 10():486. PubMed ID: 31156534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tau Oligomer-Containing Synapse Elimination by Microglia and Astrocytes in Alzheimer Disease.
    Taddei RN; Perbet R; Mate de Gerando A; Wiedmer AE; Sanchez-Mico M; Connors Stewart T; Gaona A; Melloni A; Amaral AC; Duff K; Frosch MP; Gómez-Isla T
    JAMA Neurol; 2023 Nov; 80(11):1209-1221. PubMed ID: 37812432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of aluminum with paired helical filament tau is involved in neurofibrillary pathology of Alzheimer's disease.
    Shin RW
    Gerontology; 1997; 43 Suppl 1():16-23. PubMed ID: 9187935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TDP-43 pathology is associated with increased tau burdens and seeding.
    Tomé SO; Tsaka G; Ronisz A; Ospitalieri S; Gawor K; Gomes LA; Otto M; von Arnim CAF; Van Damme P; Van Den Bosch L; Ghebremedhin E; Laureyssen C; Sleegers K; Vandenberghe R; Rousseau F; Schymkowitz J; Thal DR
    Mol Neurodegener; 2023 Sep; 18(1):71. PubMed ID: 37777806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dityrosine Cross-links are Present in Alzheimer's Disease-derived Tau Oligomers and Paired Helical Filaments (PHF) which Promotes the Stability of the PHF-core Tau (297-391) In Vitro.
    Maina MB; Al-Hilaly YK; Oakley S; Burra G; Khanom T; Biasetti L; Mengham K; Marshall K; Harrington CR; Wischik CM; Serpell LC
    J Mol Biol; 2022 Oct; 434(19):167785. PubMed ID: 35961386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteasome inhibition by paired helical filament-tau in brains of patients with Alzheimer's disease.
    Keck S; Nitsch R; Grune T; Ullrich O
    J Neurochem; 2003 Apr; 85(1):115-22. PubMed ID: 12641733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations between quantitative [
    Timmers T; Ossenkoppele R; Wolters EE; Verfaillie SCJ; Visser D; Golla SSV; Barkhof F; Scheltens P; Boellaard R; van der Flier WM; van Berckel BNM
    Alzheimers Res Ther; 2019 Jul; 11(1):60. PubMed ID: 31272512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylation of different tau sites during progression of Alzheimer's disease.
    Neddens J; Temmel M; Flunkert S; Kerschbaumer B; Hoeller C; Loeffler T; Niederkofler V; Daum G; Attems J; Hutter-Paier B
    Acta Neuropathol Commun; 2018 Jun; 6(1):52. PubMed ID: 29958544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations Between Amyloid and Tau Pathology, and Connectome Alterations, in Alzheimer's Disease and Mild Cognitive Impairment.
    King-Robson J; Wilson H; Politis M;
    J Alzheimers Dis; 2021; 82(2):541-560. PubMed ID: 34057079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Artificial intelligence-derived neurofibrillary tangle burden is associated with antemortem cognitive impairment.
    Marx GA; Koenigsberg DG; McKenzie AT; Kauffman J; Hanson RW; Whitney K; Signaevsky M; Prastawa M; Iida MA; White CL; Walker JM; Richardson TE; Koll J; Fernandez G; Zeineh J; Cordon-Cardo C; Crary JF; Farrell K;
    Acta Neuropathol Commun; 2022 Oct; 10(1):157. PubMed ID: 36316708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurofibrillary pathology and aluminum in Alzheimer's disease.
    Shin RW; Lee VM; Trojanowski JQ
    Histol Histopathol; 1995 Oct; 10(4):969-78. PubMed ID: 8574016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.